This mechanism study revealed for the first time that CASC19 could function as a ceRNA to promote autophagy and hence increase the radioresistance of NPC by suppressing miR-340-3p and increasing the expression of mRNA FKBP5, which might provide a new regulatory target of improving the efficacy of NPC radiotherapy. Here, CASC19 is linked to nasopharyngeal carcinoma.